CareDx, Inc (CDNA) vs Tango Therapeutics, Inc. (TNGX)
A side-by-side comparison of CareDx, Inc and Tango Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDNA
CareDx, Inc
$63.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNGX
Tango Therapeutics, Inc.
$21.90HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CDNA vs TNGX
growth of $100 · dividends reinvested · last 6yCDNA +103.5% (+12.6%/yr)TNGX +125.6% (+14.5%/yr)TNGX compounded faster over this window
CDNA TNGX
CDNA vs TNGX: by the numbers
- •TNGX is the larger company ($3.57B vs $3.30B market cap).
- •CDNA is profitable (24.23% net margin) while TNGX runs a net loss (-229.92%).
- •TNGX grew revenue faster over the past five years (19.14% vs 12.56% CAGR).
Metrics side by side
Valuation
| Metric | CDNA | TNGX |
|---|---|---|
| P/E ratio | 30.80 | N/A |
| Forward P/E | 53.26 | N/A |
| P/S ratio | 7.20 | 66.26 |
| P/B ratio | 7.75 | 3.48 |
| EV / EBITDA | 189.34 | N/A |
| FCF yield | 2.58% | N/A |
Profitability
| Metric | CDNA | TNGX |
|---|---|---|
| Gross margin | 70.58% | 98.25% |
| Operating margin | -0.92% | -178.39% |
| Net margin | 24.23% | -229.92% |
| ROE | 26.08% | -12.08% |
| ROIC | -0.93% | -12.91% |
Growth (annualized)
| Metric | CDNA | TNGX |
|---|---|---|
| Revenue CAGR (5Y) | 12.56% | 19.14% |
| Total return CAGR (5Y) | 1.33% | 10.60% |
Frequently asked
- Which has grown faster, CDNA or TNGX?
- Over the past five years, TNGX grew revenue faster — CDNA at a 12.56% CAGR versus TNGX at 19.14%.
- Is CDNA or TNGX more profitable?
- CDNA runs the higher net margin — CDNA at 24.23% versus TNGX at -229.92%.
- How have CDNA and TNGX total returns compared?
- Over the past 5 years, CDNA delivered 1.33% and TNGX delivered 10.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CareDx P/E ratioCareDx ROETango Therapeutics ROECareDx operating marginTango Therapeutics operating marginCareDx revenue growthTango Therapeutics revenue growthCareDx free cash flowTango Therapeutics free cash flow
CareDx & Tango Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.